Autologous Hematopoietic Stem Cell Transplantation Modulates Immunocompetent Cells and Improves β-Cell Function in Chinese Patients with New Onset of Type 1 Diabetes | Zendy

Lirong Li | Zendy; Shanmei Shen | Zendy; Jian Ouyang | Zendy; Yun Hu | Zendy; Limin Hu | Zendy; Weijuan Cui | Zendy; Ning Zhang | Zendy; Yuzheng Zhuge | Zendy; Bing Chen | Zendy; Jingyan Xu | Zendy; Dalong Zhu | Zendy

Open Access

Autologous Hematopoietic Stem Cell Transplantation Modulates Immunocompetent Cells and Improves β-Cell Function in Chinese Patients with New Onset of Type 1 Diabetes

Author(s) -

Lirong Li,

Shanmei Shen,

Jian Ouyang,

Yun Hu,

Limin Hu,

Weijuan Cui,

Ning Zhang,

Yuzheng Zhuge,

Bing Chen,

Jingyan Xu,

Dalong Zhu

Publication year - 2012

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-2188

Subject(s) - medicine , endocrinology , cd34 , insulin , autoantibody , transplantation , immunology , hematopoietic stem cell transplantation , glycemic , hemoglobin , cd8 , haematopoiesis , type 1 diabetes , stem cell , diabetes mellitus , antibody , immune system , biology , genetics

Autologous hematopoietic stem cell transplantation (AHSCT) has the potential to induce clinical remission in patients with newly diagnosed type 1 diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research